Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 02 Mar 2023 for Abbott Laboratories, €587k.
Filing timeline
BuySaleJohn M. Capek
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
John M. Capek: trading record in brief
One sale dominates the record of John M. Capek, Executive Vice President of Abbott Laboratories: EUR 17,860,482 on December 13, 2021. That sale comes ahead of EUR 4,949,628 on August 27, 2020 and EUR 3,961,580 on February 21, 2017, two more among the 7 sales in the record, which total EUR 38,319,265 with a median of EUR 3,594,035. No purchase is recorded.
The record holds 30 filings, published from February 23, 2016 to March 2, 2023. There are also 16 grants and 7 option exercises. The yearly curve is fairly flat, from 2 to 4 a year, with a spike at 7 in 2020. Nothing falls in the last twelve months. Filings are published a median of 2 days after the trade.
The count of trades by Capek within 30 days of colleagues at Abbott Laboratories is 4, 4 and 3. All in the same direction. Names in order: Andrew H. Lane, Daniel Gesua Sive Salvadori and Andrea F. Wainer.
Companies and markets linked to John M. Capek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
6,247 shares@ US$99.779.8% of flowCommon shares without par valueSEC:0001415889-23-003897:0
15,855 shares0Common shares without par valueSEC:0001415889-23-003048:0
7,086 shares@ US$122.4113.0% of flowCommon shares without par valueSEC:0001415889-22-002188:0
15,523 shares0Common shares without par valueSEC:0001415889-22-001732:0
149,600 shares@ US$135.0532.3% of flowCommon shares without par valueSEC:0001415889-21-005966:1
149,600 shares@ US$34.9477.2% of flowCommon shares without par valueSEC:0001415889-21-005966:0
9,267 shares@ US$121.581.7% of flowCommon shares without par valueSEC:0001415889-21-001199:0
13,865 shares0Common shares without par valueSEC:0001415889-21-000887:0
52,300 shares@ US$27.036.6% of flowCommon shares without par valueSEC:0001179110-20-009446:0
52,300 shares@ US$111.8627.2% of flowCommon shares without par valueSEC:0001179110-20-009446:1
50,100 shares@ US$22.395.7% of flowCommon shares without par valueSEC:0001179110-20-005070:0
31,399 shares@ US$95.6315.2% of flowCommon shares without par valueSEC:0001179110-20-005070:1
18,701 shares@ US$96.289.1% of flowCommon shares without par valueSEC:0001179110-20-005070:2
8,704 shares@ US$79.193.4% of flowCommon shares without par valueSEC:0001179110-20-002915:0
16,969 shares0Common shares without par valueSEC:0001179110-20-002279:0
46,900 shares@ US$26.193.8% of flowCommon shares without par valueSEC:0001179110-19-008035:0
46,900 shares@ US$85.0012.4% of flowCommon shares without par valueSEC:0001179110-19-008035:1
9,132 shares@ US$77.232.2% of flowCommon shares without par valueSEC:0001179110-19-003112:0
19,367 shares0Common shares without par valueSEC:0001179110-19-002638:0
64,900 shares@ US$26.025.0% of flowCommon shares without par valueSEC:0001179110-18-009933:0
64,900 shares@ US$65.0012.4% of flowCommon shares without par valueSEC:0001179110-18-009933:1
7,958 shares@ US$60.551.1% of flowCommon shares without par valueSEC:0001179110-18-003301:0
28,276 shares0Common shares without par valueSEC:0001179110-18-002532:0
10,815 shares@ US$45.461.3% of flowCommon shares without par valueSEC:0001179110-17-003677:0
93,400 shares@ US$26.706.4% of flowCommon shares without par valueSEC:0001179110-17-002952:1
25 of 30 declarations
